Literature DB >> 30821815

P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination.

Karoline Henriksen1, Nanna Rørbo2, Morten Levin Rybtke1, Mark Grevsen Martinet1, Tim Tolker-Nielsen1, Niels Høiby1,3, Mathias Middelboe2, Oana Ciofu1.   

Abstract

Phage therapy has shown promising results in the treatment of Pseudomonas aeruginosa biofilm infections in animal studies and case reports. The aim of this study was to quantify effects of phage treatments on P. aeruginosa biofilm production and structure. Confocal scanning microscopy was used to follow the interaction between a cocktail of three virulent phages and P. aeruginosa flow-cell biofilms. The role of (i) biofilm age, (ii) repeated phage treatments, (iii) alginate production and (iv) the combination with sub-MIC levels of ciprofloxacin was investigated. Single phage treatment in the early biofilm stages significantly reduced P. aeruginosa PAO1 biovolume (85%-98% reduction). Repeated phage treatments increased the biovolume from 18.25 (untreated biofilm) to 22.24 and 31.07 µm3/µm2 for biofilms treated with phages twice and thrice, respectively. Alginate protected against the phage treatment as the live biovolume remained unaffected by the phage treatment in the mucoid biofilm (20.11 µm3/µm2 in untreated and 21.74 µm3/µm2 in phage-treated biofilm) but decreased in the PAO1 biofilm from 27.35 to 0.89 µm3/µm2. We show that the combination of phages with antibiotics at sub-MIC levels caused a ∼6 log units reduction in the abundance of P. aeruginosa cells in biofilms and that phage treatment increased the size of microcolonies in flow-cell system. © FEMS 2019.

Entities:  

Keywords:  zzm321990 Pseudomonas aeruginosazzm321990 ; bacteriophage; biofilm; ciprofloxacin

Mesh:

Substances:

Year:  2019        PMID: 30821815     DOI: 10.1093/femspd/ftz011

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  14 in total

Review 1.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 2.  Bacteriophages and Lysins in Biofilm Control.

Authors:  Marzanna Łusiak-Szelachowska; Beata Weber-Dąbrowska; Andrzej Górski
Journal:  Virol Sin       Date:  2020-03-03       Impact factor: 4.327

Review 3.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

Review 4.  Deconstructing the Phage-Bacterial Biofilm Interaction as a Basis to Establish New Antibiofilm Strategies.

Authors:  Annegrete Visnapuu; Marie Van der Gucht; Jeroen Wagemans; Rob Lavigne
Journal:  Viruses       Date:  2022-05-16       Impact factor: 5.818

5.  Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model.

Authors:  Yu Lin; Diana Quan; Rachel Yoon Kyung Chang; Michael Y T Chow; Yuncheng Wang; Mengyu Li; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Jian Li; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2020-11-27       Impact factor: 5.571

Review 6.  Tolerance and resistance of microbial biofilms.

Authors:  Oana Ciofu; Claus Moser; Peter Østrup Jensen; Niels Høiby
Journal:  Nat Rev Microbiol       Date:  2022-02-03       Impact factor: 78.297

7.  Quantitative Models of Phage-Antibiotic Combination Therapy.

Authors:  Rogelio A Rodriguez-Gonzalez; Chung Yin Leung; Benjamin K Chan; Paul E Turner; Joshua S Weitz
Journal:  mSystems       Date:  2020-02-04       Impact factor: 7.324

Review 8.  Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?

Authors:  Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2019-10-11

Review 9.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

10.  The Role of Drug Repurposing in the Development of Novel Antimicrobial Drugs: Non-Antibiotic Pharmacological Agents as Quorum Sensing-Inhibitors.

Authors:  Márió Gajdács; Gabriella Spengler
Journal:  Antibiotics (Basel)       Date:  2019-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.